Loading Events

« All Events

  • This event has passed.

Glasgow Pathology 2020

December 6 2020 - December 8 2020

The XXXIII International Congress of the International Academy of Pathology and the 32nd Congress of the European Society of Pathology

Jointly sponsored by the British Division of the IAP and the European Society of Pathology.

The Virtual ESP/IAP 2020 Congress will take place from 6 to 8 December 2020 and has been granted 18 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).

Session topics include:

  • Infectious disease pathology: COVID-19 in the autopsy room
  • Genomics for all cancer patients
  • Challenges in lung and thoracic pathology

Registration fees have been significantly reduced for this event. For more information on this, registering for the event and a full programme please visit the European Society of Pathology website.

Details

Start:
December 6 2020
End:
December 8 2020
Event Categories:
, ,
Event Tags:
, , , , , ,
Website:
https://www.esp-congress.org/

Venue

Online
United Kingdom
With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
 
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
 
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
 
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.